المؤلفون: Bixler Sl, Joshua A. Johnson, Keersten M. Ricks, Gibson Km, Ondraya Frick, Pitt Mlm, David N Dyer, Franco Rossi, Moreau Am, Jeffrey M. Smith, Timothy D. Minogue, Heather L. Esham, Bloomfield H, Aysegul Nalca, Kuehnert Pa, Xiankun Zeng, DiPinto N, Jun Liu, Delp Kl, Jeffrey W. Koehler, Alexandra Jay, Tostenson S, Charles J. Shoemaker, Kristen Akers, Brian J. Kearney, Kerry Berrier, Coyne, Jay W. Hooper, Christopher P. Stefan, Clements Tl

مصطلحات موضوعية: Pathology, medicine.medical_specialty, Coronavirus disease 2019 (COVID-19), business.industry, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Respiratory disease, Severe disease, Disease, medicine.disease, Nonhuman primate, medicine, Clinical endpoint, Small particles, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::5a035ab654f8b3aa052b6f0bce759636
https://doi.org/10.1101/2021.04.27.441510

المؤلفون: Asnagli, H?l?ne, Martire, Delphine, Belmonte, Nathalie, Quentin, Julie, Bastian, Herv?, Boucard-Jourdin, Mathilde, Fall, Papa, Mausset-Bonnefont, Anne-Laure, Mantello-Moreau, Am?lie, Rouquier, Sandrine, Marchetti, Ir?ne, Jorgensen, Christian, Foussat, Arnaud, Louis-Plence, Pascale

المصدر: Arthritis Research & Therapy (formerly Arthritis Research); June 2014, Vol. 16 Issue: 3 pR115-R115, 1p